Haiti Country Profile

Haiti country flag

Haiti Country Profile

Discover more about CDC’s work in Haiti by viewing our detailed country profilepdf icon

Country Overview

CDC’s Haiti office opened in 2002 and continues to work in collaboration with the Ministry of Public Health and Population to support national efforts to prevent the transmission of HIV; increase the accessibility and quality of HIV clinical services and treatment; increase patient adherence and retention in treatment; strengthen HIV surveillance, epidemiology, laboratory, and health information management systems; and expand the availability of treatment for multidrug-resistant tuberculosis. Additionally, CDC works with partners such as the Pan-American Health Organization and other non-governmental organizations to provide technical assistance and logistical support focused on rebuilding and strengthening Haiti’s laboratory systems.

Per Capita GNI

$1,250

(2020)

Population (million)

11.40

(2020)

Under 5 Mortality

63/1,000 Live Births

(2019)

Life Expectancy

64 Years

(2019)

Estimated HIV Prevalence

1.9%

(Ages 15-49): (2020)

Estimated AIDS Deaths

1,600

(Age≥15) (2020)

TB Treatment Success Rate

82%

(2018)

Estimated TB Incidence

170/100,000

(2019)

TB Mortality (HIV Related)

8.9/100,000

(2019)

Estimated Orphans Due to AIDS

67,000

(2020)

TB patients with known HIV-status who are HIV-positive

16%

(2019)

Reported Number Receiving Antiretroviral Therapy (ART)

118,519

(Age≥15) (2020)


Strategic Focus

The Centers for Disease Control and Prevention (CDC) Haiti office opened in 2002. Working in collaboration with Haiti’s Ministry of Public Health and Population (MSPP), CDC is supporting the national response to HIV/AIDS by preventing the transmission of HIV; providing and increasing the accessibility and quality of HIV clinical services, and treatment; increasing patient adherence and retention in treatment; strengthening surveillance, epidemiology, laboratory, and health management information systems; and expanding multidrug-resistant tuberculosis (MDR-TB) treatment availability.

 

Strengthening Health Systems: To ensure a sustainable and robust health system, CDC supports critical staffing needs, training programs with the greatest impact for medical and paramedical personnel, strengthening of MSPP governance and financial management mechanisms, strategic information systems and data use for informed decision-making.

Strengthening Laboratory Systems and Networks: CDC collaborates with the National Public Health Laboratory (LNSP) to develop multiple testing capacities, including Polymerase Chain Reaction (PCR) for diagnosis of HIV in infants, scale up of viral load testing, and testing for opportunistic infections in HIV-infected people. CDC has helped the country to establish an external quality assurance program and a training curriculum to build capacity for lab accreditation.

Strengthening Surveillance and Health Information Systems: CDC is increasing access to strategic information by supporting MSPP to establish and monitor integrated health management information systems including an electronic medical records (EMR) systems that cover more than 95% of patients on antiretroviral treatment (ART) in Haiti and a longitudinal web-based reporting and surveillance system for HIV and TB.

social media card. photo, boy.

Social Media Cardimage icon

CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries.

image icon

social media card. photo, healthcare worker and patient

Social Media Cardimage icon

TB is the #1 killer of people living with HIV. TB preventative treatment protects those with HIV from contracting TB Disease. It’s effective, It’s affordable. It saves lives.

image icon

social media card. photo of a boy

Social Media Cardimage icon

CDC’s innovative efforts to Find, Cure, and Prevent TB are creating a safer America and a safer world.

image icon

Page last reviewed: September 30, 2021, 12:00 AM